Clinical Trial Update: A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer [Phase 4]

View source ↗

Summary

This document reports the completion of a prospective, open-label Phase 4 trial evaluating anastrozole in postmenopausal women with hormone-sensitive advanced b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED